Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01408563 · OUTCOME

Median Thrombopoietin Levels After Transplant

Reduced Intensity Double Umbilical Cord Blood Transplantation · Source last updated 2019-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
pg/mL
Interval / dispersion
Full Range
Time frame
30 Days

Groups in this outcome

Fludarabine/Melphalan/TBI

All patients receive same therapy Fludarabine: 30 mg/m2/day IV x 6 days Melphalan: 100 mg/m2/day IV x 1 day Total Body Radiation: 200 cGy on Day 0 Cord Blood: 2 cord blood units IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Fludarabine/Melphalan/TBI31

Reported measurements

Source class 1
Values in pg/mL · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Fludarabine/Melphalan/TBI2500Not reported3204000Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        320
        upper Limit
        4000
        value
        2500
denoms
  1. counts
    1. group Id
      OG000
      value
      31
    units
    Participants
dispersion Type
Full Range
groups
  1. description
    All patients receive same therapy Fludarabine: 30 mg/m2/day IV x 6 days Melphalan: 100 mg/m2/day IV x 1 day Total Body Radiation: 200 cGy on Day 0 Cord Blood: 2 cord blood units IV
    id
    OG000
    title
    Fludarabine/Melphalan/TBI
param Type
MEDIAN
reporting Status
POSTED
time Frame
30 Days
title
Median Thrombopoietin Levels After Transplant
type
SECONDARY
unit Of Measure
pg/mL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice